Luminate: Valuation, Funding & Investors
Luminate is a healthcare technology company that enables patients to receive cancer treatments at home through coordinated care with oncologists and insurers and a suite of supportive medical devices. The company operates nurse-led home infusion programs and is developing auto-injector and monitoring technologies to enable patient-led administration of certain cancer therapies.
Leadership & Board
- Current Number of Employees
- 21
- Current LinkedIn Followers
- 780
Latest Estimated Valuation
- Total Amount Raised
- $21M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $21M
- Latest Funding Round
- Series A
Company Momentum Positive
Luminate LinkedIn following is relatively stable, while its workforce is growing, indicating business expansion.
Employee Trend
Luminate had 21 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Luminate had 780 followers as of October 26, 2026. The number of followers decreased by 1 (0.13%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 07, 2026 | Series A | $21.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Y Combinator | Series A |
| Artis Ventures | Series A |
| 8VC | Series A |
| Lachy Groom | Series A |
| Atlantic Bridge | Series A |
| Western Alliance Life Sciences | Series A |
| Faber | Series A |
| SciFounders | Series A |
Similar Companies
A snapshot of private companies similar to Luminate, helping you discover and navigate related company profiles.
